Conrad Wai, CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 300,994 shares at $3.32 ($996K) on 2025-07-23, disclosed to the SEC on 2025-07-24.
Scheduled sale ($996k) by CEO, Counterpart Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.29 | 118,600 | $390K | 39.2% |
| 2 | $3.32 | 91,197 | $303K | 30.4% |
| 3 | $3.32 | 91,197 | $303K | 30.4% |
| Total | $3.31 avg | 300,994 | $996K | 100% |
| Filing → |
| CLOV | SELL | 2026-05-28 | $879K | — | Filing → |
| CLOV | SELL | 2025-07-10 | $50K | — | Filing → |